1

Zaid Jilani – Hillary Clinton’s “Corrupt Establishment” Is Now Advising Donald Trump

“THE ESTABLISHMENT,” Donald Trump famously said during his closing argument for the presidency, “has trillions of dollars at stake in this election.” He described “a global power structure that is responsible for the economic decisions that have robbed our working class, stripped our country of its wealth and put that money into the pockets of a handful of large corporations …

1

Blaming Trump’s Win on the Age Group Least Responsible for It

Before the election, corporate media nonsensically tried to blame the rise of Donald Trump on Millennials (FAIR.org, 10/10/16)—and now, after the election, the Washington Post is still at it. “Yes, You Can Blame Millennials for Hillary Clinton’s Loss” was the headline over a piece by the Post‘s Aaron Blake (12/2/16). “Clinton campaign manager Robby Mook said Thursday that one particular …

1

Leid Stories—TrumpWorld Shapes Up. Scared Yet?—12.01.16

President-elect Donald Trump’s Cabinet and top-staff picks so far are an interesting lot and a strong indication of where he and his new administration—and, by extension, the rest of us—are headed.

1

Jesse Eisinger and Justin Elliott – These Professors Make More Than a Thousand Bucks an Hour Peddling Mega-Mergers

IF THE GOVERNMENT ENDS UP approving the $85 billion AT&T-Time Warner merger, credit won’t necessarily belong to the executives, bankers, lawyers, and lobbyists pushing for the deal. More likely, it will be due to the professors. A serial acquirer, AT&T must persuade the government to allow every major deal. Again and again, the company has relied on economists from America’s …

Deirdre Fulton – ‘Enough to Make Me Gag’: Warren and Sanders Decry Latest Big Pharma Giveaway

U.S. Sens. Bernie Sanders (I-Vt.) and Elizabeth Warren (D-Mass.) have come out swinging against a heavily lobbied healthcare bill they say has been “hijacked” by Big Pharma. The 21st Century Cures Act, poised to pass the House on Wednesday and the Senate soon after, would ostensibly advance medical innovation with increased funding for initiatives like Vice President Joe Biden’s cancer …